SMED - SMED STOCK NEWS

Sharps Compliance Corp. (SMED) has partnered with PharMerica Corporation to expand the availability of its MedSafe medication management solution in Long-Term Care (LTC) facilities. This partnership aims to enhance the efficiency of unused medication management across PharMerica's network of over 2,500 LTC facilities in the U.S. Since its launch in 2014, MedSafe has collected over 4.7 million pounds of unused medications, offering significant cost savings for LTC facilities. The MedSafe system is designed to be compliant with DEA regulations and aims to improve safety and reduce operational expenses.

Sharps Compliance Corp. (NASDAQ: SMED) will announce its second quarter 2022 financial results for the period ending December 31, 2021, on January 26, 2022. A conference call and webcast will follow at 11:00 a.m. ET, discussing key financial outcomes and business strategies. Domestic callers can join at (888) 506-0062, while international participants can call (973) 528-0011. A replay will be available until February 25, 2022. The company specializes in regulated medical waste management services for various markets.

Sharps Compliance Corp. (NASDAQ: SMED) has appointed Gary R. Enzor to its Board of Directors. Enzor brings a wealth of experience from Fortune 50 companies across multiple sectors, including transportation and technology. He is currently a director at Boasso Global and has previously held the role of Chairman and CEO at Quality Distribution. Leadership expressed confidence in Enzor's ability to contribute to the company's growth as it enhances its waste management solutions.

Sharps Compliance reported a 6% revenue increase to $13.9 million for Q1 fiscal 2022, driven by a 9% rise in professional market billings and an 11% growth in unused medication revenue. However, gross margin fell to 25% from 28% due to revenue recognition issues. The company incurred an operating loss of $1 million and a net loss of $0.8 million, equating to a loss of $0.04 per share. Sharps completed a secondary offering for net proceeds of $17 million and maintained a cash balance of $41.2 million. They anticipate growth through acquisitions and continued emphasis on the unused medication market.

Sharps Compliance Corp. (NASDAQ: SMED) announced the acquisition of Affordable Medical Waste (AMW) for $2.2 million. AMW, a respected provider of medical waste solutions in Indiana, serves over 500 customer locations. This acquisition aligns with Sharps' growth strategy to enhance route density and strengthen its position in the waste management sector. CEO David P. Tusa emphasized the opportunity to capitalize on an active pipeline of acquisitions, supported by Sharps' strong balance sheet.

Sharps Compliance Corp. (NASDAQ: SMED) will announce its Q1 2022 financial results on October 27, 2021, before market opening. A conference call at 11:00 a.m. ET will follow, discussing financials, market initiatives, and business strategy. Domestic callers can join at (888) 506-0062, while international callers can dial (973) 528-0011, using code 896291. A replay will be available until November 26, 2021. Sharps Compliance specializes in regulated medical and hazardous waste management solutions in healthcare sectors.

Sharps Compliance Corp. (Nasdaq: SMED) closed an underwritten public offering of 2,070,000 shares at $8.65 each, raising approximately $17 million after discounts and expenses. The offering included the underwriter's purchase of an additional 270,000 shares for over-allotments. Proceeds will be used for acquisitions and general corporate purposes. The offering was registered under an effective shelf registration statement filed on June 30, 2021. Roth Capital Partners acted as the sole manager for this offering.

Sharps Compliance Corp. (Nasdaq: SMED) announced an underwritten public offering of 1,800,000 shares at $8.65 per share, with net proceeds estimated at $14.8 million. An additional 270,000 shares may be offered to underwriters for overallotments. Closing is expected by August 30, 2021. Proceeds will fund company acquisitions and general corporate purposes. Roth Capital Partners manages the offering.

Sharps Compliance Corp. (Nasdaq: SMED) announced plans for an underwritten public offering of its common stock, including an option for underwriters to purchase an additional 15%. The proceeds will be allocated for acquisitions and general corporate purposes. The offering will be conducted under a shelf registration statement effective since June 30, 2021. Roth Capital Partners is the sole manager for this offering. Completion is subject to market conditions, and there are no guarantees regarding its size or timing.